{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:05:01Z","timestamp":1784909101686,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymgmr.2026.101313","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:07:34Z","timestamp":1777597654000},"page":"101313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevalence and sociodemographic, clinical, and genetic characteristics of Fabry disease in north-central Chile, 2013\u20132023"],"prefix":"10.1016","volume":"47","author":[{"given":"Sergio","family":"Royo Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Castillo-Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Molt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basthian","family":"Cortes Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Ram\u00edrez-Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"30","key":"10.1016\/j.ymgmr.2026.101313_bb0005","first-page":"1","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101313_bb0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymgme.2018.06.004","article-title":"European expert consensus statement on therapeutic goals in fabry disease","volume":"124","author":"Wanner","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101313_bb0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.amjms.2020.07.011","article-title":"When and how to diagnose fabry disease in clinical practice","volume":"360","author":"Michaud","year":"2020","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ymgmr.2026.101313_bb0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13023-023-02937-6","article-title":"Safety and efficacy of pegunigalsidase alfa in patients with fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study","volume":"18","author":"Linhart","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101313_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1395287","article-title":"Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of fabry disease","volume":"15","author":"Germain","year":"2024","journal-title":"Front. Genet."},{"issue":"7","key":"10.1016\/j.ymgmr.2026.101313_bb0030","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cns.12542","article-title":"Pain in fabry disease: practical recommendations for diagnosis and treatment","volume":"22","author":"Politei","year":"2016","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101313_bb0035","first-page":"1","article-title":"A review and recommendations for oral chaperone therapy in adult patients with fabry disease","volume":"19","author":"Nowicki","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101313_bb0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"Jama"},{"issue":"7","key":"10.1016\/j.ymgmr.2026.101313_bb0045","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ekir.2023.04.009","article-title":"Population frequency of undiagnosed fabry disease in the general population","volume":"8","author":"Kermond-Marino","year":"2023","journal-title":"Kidney Int. Rep."},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101313_bb0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/jmedgenet-2017-104863","article-title":"Agalsidase alfa versus agalsidase beta for the treatment of fabry disease: an international cohort study","volume":"55","author":"Arends","year":"2018","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2026.101313_bb0055","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s13023-025-04098-0","article-title":"Risk factors, stroke rates and aspirin prescribing trends in the Canadian fabry disease initiative cohort","volume":"20","author":"Th\u00e9berge","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101313_bb0060","author":"de Salud"},{"key":"10.1016\/j.ymgmr.2026.101313_bb0065","author":"Fondo Nacional de Salud"},{"key":"10.1016\/j.ymgmr.2026.101313_bb0070","volume":"2024","author":"Instituto Nacional de Estad\u00edsticas","year":"2024","journal-title":"Censo"},{"key":"10.1016\/j.ymgmr.2026.101313_bb0075","author":"Instituto Nacional de Estad\u00edsticas"},{"key":"10.1016\/j.ymgmr.2026.101313_bb0080","author":"Ministerio de Desarrollo Social y Familia. Encuesta CASEN"},{"key":"10.1016\/j.ymgmr.2026.101313_bb0085","author":"Fondo Nacional de Salud"},{"key":"10.1016\/j.ymgmr.2026.101313_bb0090","author":"Ministerio de Salud"},{"key":"10.1016\/j.ymgmr.2026.101313_bb0095","author":"Servicio de Salud Coquimbo"},{"key":"10.1016\/j.ymgmr.2026.101313_bb0100","author":"Instituto Nacional de Estad\u00edsticas"},{"issue":"4","key":"10.1016\/j.ymgmr.2026.101313_bb0105","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jmg-2022-108523","article-title":"Prevalence of fabry disease-causing variants in the UK biobank","volume":"60","author":"Gilchrist","year":"2023","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.ymgmr.2026.101313_bb0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/gim.2014.120","article-title":"Fabry disease in infancy and early childhood: a systematic literature review","volume":"17","author":"Laney","year":"2015","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101313_bb0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ymgme.2021.05.004","article-title":"Prevalence of patients with lysosomal storage disorders and peroxisomal disorders: a nationwide survey in Japan","volume":"133","author":"Koto","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"8","key":"10.1016\/j.ymgmr.2026.101313_bb0120","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00431-017-2950-8","article-title":"Newborn screening for fabry disease in the north-west of Spain","volume":"176","author":"Colon","year":"2017","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgmr.2026.101313_bb0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12882-022-02805-8","article-title":"The prevalence of fabry disease in a statewide chronic kidney disease cohort \u2013 outcomes of the aCQuiRE (Ckd.Qld fabRy epidemiology) study","volume":"23","author":"Mallett","year":"2022","journal-title":"BMC Nephrol."},{"issue":"18","key":"10.1016\/j.ymgmr.2026.101313_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251810104","article-title":"Prevalence of fabry disease in patients on dialysis in France","volume":"25","author":"Sens","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ymgmr.2026.101313_bb0135","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3390\/genes14091804","article-title":"Sex differences in Anderson\u2013Fabry cardiomyopathy: Clinical, genetic, and imaging analysis in women","volume":"14","author":"Faro","year":"2023","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.ymgmr.2026.101313_bb0140","first-page":"414","article-title":"Fabry disease phenotyping in women from the complete romanian cohort - time for early diagnostic awareness","volume":"62","author":"Murs\u0103","year":"2024","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.ymgmr.2026.101313_bb0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13148-021-01019-3","article-title":"DNA methylation impact on fabry disease","volume":"13","author":"Di Risi","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.ymgmr.2026.101313_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.12914","article-title":"Time delays in the diagnosis and treatment of fabry disease","volume":"71","author":"Reisin","year":"2017","journal-title":"Int. J. Clin. Pract."},{"issue":"5","key":"10.1016\/j.ymgmr.2026.101313_bb0155","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2016090964","article-title":"Characterization of classical and nonclassical fabry disease: a multicenter study","volume":"28","author":"Arends","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.ymgmr.2026.101313_bb0160","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1159\/000485929","article-title":"Screening for fabry disease in kidney disease: a cross-sectional study in males and females","volume":"42","author":"De Souza Sodre","year":"2017","journal-title":"Kidney Blood Press. Res."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101313_bb0165","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12882-023-03138-w","article-title":"The evolution of the initial manifestations and renal involvement of chinese patients with classical and late-onset fabry disease at different sexes and ages","volume":"24","author":"Guo","year":"2023","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.ymgmr.2026.101313_bb0170","first-page":"73","article-title":"Fabry disease in a japanese population-molecular and biochemical characteristics","volume":"17","author":"Sakuraba","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101313_bb0175","first-page":"414","article-title":"Fabry disease: evidence for a regional founder effect of the GLA gene mutation 30delG in brazilian patients","volume":"1","author":"De Alencar","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101313_bb0180","article-title":"Underdiagnosis of fabry disease in minority ethnic groups","volume":"42","author":"Church Smith","year":"2025","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgmr.2026.101313_bb0185","article-title":"Expert review in diagnostic, therapeutic and follow-up of fabry disease in latin america based on patient care standards","volume":"43","author":"Giugliani","year":"2025","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"3","key":"10.1016\/j.ymgmr.2026.101313_bb0190","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ymgme.2018.04.007","article-title":"The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with fabry disease \u2013 a systematic literature review by a european panel of experts","volume":"126","author":"Spada","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101313_bb0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2021.12.004","article-title":"Early start of enzyme replacement therapy in pediatric male patients with classical fabry disease is associated with attenuated disease progression","volume":"135","author":"van der Veen","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.ymgmr.2026.101313_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease - a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ymgmr.2026.101313_bb0205","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.kint.2016.10.004","article-title":"Screening, diagnosis, and management of patients with fabry disease: conclusions from a \u201ckidney disease: improving global outcomes\u201d (KDIGO) controversies conference","volume":"91","author":"Schiffmann","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgmr.2026.101313_bb0210","first-page":"8","article-title":"Renal manifestations of fabry disease: a narrative review","author":"Silva","year":"2021","journal-title":"Can. J. Kidney Health Dis."},{"issue":"FI2","key":"10.1016\/j.ymgmr.2026.101313_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/eux261","article-title":"Ventricular arrhythmia and sudden cardiac death in fabry disease: a systematic review of risk factors in clinical practice","volume":"20","author":"Baig","year":"2018","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.ymgmr.2026.101313_bb0220","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.acvd.2019.01.002","article-title":"Fabry disease in cardiology practice: literature review and expert point of view","volume":"112","author":"Hag\u00e8ge","year":"2019","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2026.101313_bb0225","doi-asserted-by":"crossref","first-page":"5","DOI":"10.47162\/RJME.62.1.01","article-title":"Fabry disease \u2013 current data and therapeutic approaches","volume":"62","author":"Dinu","year":"2021","journal-title":"Romanian J. Morphol. Embryol."},{"key":"10.1016\/j.ymgmr.2026.101313_bb0230","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12883-017-0810-9","article-title":"A comparison of central nervous system involvement in patients with classical fabry disease or the later-onset subtype with the IVS4+919G>a mutation","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ymgmr.2026.101313_bb0235","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s13760-019-01138-y","article-title":"Multidisciplinary approach to fabry disease: from the eye of a neurologist","volume":"120","author":"\u0130nan","year":"2020","journal-title":"Acta Neurol. Belg."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221442692600025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221442692600025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:18:05Z","timestamp":1784906285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221442692600025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"alternative-id":["S221442692600025X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101313","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and sociodemographic, clinical, and genetic characteristics of Fabry disease in north-central Chile, 2013\u20132023","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101313"}}